Portland, OR — 01/02/2018 — Cancer Immunotherapy Market Overview
Cancer Immunotherapy Market is expected to grow at a CAGR of 15.7% from 2017 to 2025. Immunotherapy is the process of treating diseases with the help of a persons own immune system to fight against diseases such as cancer. The process of cancer immunotherapy can be done in different ways such as stimulating the patients immune system to work harder or smarter to attack cancer cells and the patient can be given artificial immune-system protein. Immunotherapy helps in boosting the immune system to attack the cancer cells specifically.
According to type, the Cancer Immunotherapy Market is divided into monoclonal antibodies, immunomodulators, cancer vaccines, and checkpoint inhibitors. According to application, the market is divided into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma, head and neck cancer, and others. Geographic breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.
Cancer Immunotherapy Market Dynamics:
Increasing funding from different government and private organizations for the research and development of cancer immunotherapy.
Increasing incidence of cancer worldwide.
Rising approvals for the clinical trials of cancer immunotherapy.
Rising acceptance of cancer immunotherapy
High cost of cancer immunotherapy.
Cancer Immunotherapy Market Players:
The top players in the global cancer immunotherapy market include Amgen, AstraZeneca, Bayer AG, F. Hoffman La-Roche, Bristol-Myers Squibb, Janssen Global Services, LLC, Eli Lilly and Company, Merck & Co., Inc., Novartis, and Pfizer. Market players for cancer immunotherapy market are adopting different strategies such as product development, product approval, acquisition, and collaboration to keep pace with the evolving market trends.
Get the sample PDF Brochure of market study @ https://www.researchbeam.com/global-cancer-immunotherapy-size-trend-share-opportunity-analysis-and-forecast-2014-2025-market/request-sample
Head and Neck Cancer
Rest of Europe
Rest of Asia-Pacific
Rest of LAMEA
Powered by WPeMatico